No.3628
POCT Market in Japan: Key Research Findings 2024
POCT Market for FY2023 Dropped to 273,900 Million Yen, 82.1% of Previous Fiscal Year
Yano Research Institute (the President, Takashi Mizukoshi) has carried out a survey on the domestic point-of-care testing (POCT) market and has found out the market size, the trend of market players, and future perspectives.
Market Overview
The domestic point-of-care testing (POCT) market size (total 10 major categories) declined to 273,900 million yen in FY2023, representing 82.1% of the size of the previous fiscal year.From FY2021 to FY2022, the market for rapid antigen test kits for COVID-19 that use immunochromatography expanded rapidly. The growth was witnessed particularly in FY2022 as municipalities waged to secure a significant volume of test kits. Nevertheless, the sales turned to worse from May 2023, as the government reclassified Covid-19 to Class 5 disease under the Infectious Disease Act, which diminished the demand for Covid test kits at non-medical facilities.Still, the POCT market size has become more than double its size before the pandemic (a little over 100 billion yen). The COVID-19 pandemic has undoubtedly created a huge demand for rapid testing kits.
Noteworthy Topics
Emerging Demand for COVID-19/Flu Combo Rapid Test Kits
From FY2020 to FY2022, Covid-19 was by far the most widespread respiratory infection, with only a few exceptions. However, the infectious disease landscape shifted in FY2023, marked by a summer outbreak of influenza. In fact, there was a simultaneous outbreak of Covid-19 and influenza, putting significant strain on medical facilities as they managed an influx of patients.
As a result, the market for immunochromatographic clinical test kits saw a sharp rise in demand for Covid-Flu combo rapid antigen test kits in FY2023, which can detect the new coronavirus and influenza virus simultaneously.
Future Outlook
Although the government already classified Covid as a category 5 infectious disease, it is maintaining dual seasonality, peaking twice a year. As medical professionals are still warned of another outbreak, the needs for Covid-19 rapid antigen test kits are projected to remain high.
In addition, against the backdrop of the increase in the number of patients with infectious diseases other than novel coronavirus, such as influenza, streptococci, adenovirus, RS virus, and mycoplasma pneumonia, the needs for rapid tests in the early stage of these infection are on the rise. Going forward, we believe that the opportunities will grow for manufacturers to expand their offerings to include highly-sensitive rapid test kits to identify a range of viral infections, as well as for multiple infections.
Research Outline
2.Research Object： Companies developing clinical reagents and devices (Japanese companies as well as Japanese subsidiaries of overseas companies)
3.Research Methogology： Face-to-face interviews (including online interviews) by our expert researchers, surveys via telephone and email
About POCT Market
POCT (point-of-care testing) refers to the rapid analysis of specimens (e.g., blood, urine, feces, and tissue samples) conducted by healthcare professionals at clinical setting with patients, as opposed to centralized testing in a central laboratory or at an external testing center.
In this research, the size of POCT market is calculated by totaling the sales of businesses in the following ten product categories: 1) glucose analyzers, 2) HbA1c analyzers, 3) biochemical analyzers, 4) blood gas analyzers, 5) blood cell counters, 6) coagulation analyzers, 7) immunochromatography test kits (lateral flow tests), 8) immune system measuring devices, 9) urine test papers, and 10) genetic test devices. Note that the glucose analyzer here does not include self-monitoring blood glucose devices.
＜Products and Services in the Market＞
1) Glucose analyzers, 2) HbA1c analyzers, 3) biochemical analyzers, 4) blood gas analyzers, 5) blood cell counters, 6) coagulation analyzers, 7) immunochromatography test kits (lateral flow tests), 8) immune system measuring devices, 9) urine test papers, and 10) genetic test devices
Published Report
Contact Us
The copyright and all other rights pertaining to this report belong to Yano Research Institute.
Please contact our PR team when quoting the report contents for the purpose other than media coverage.
Depending on the purpose of using our report, we may ask you to present your sentences for confirmation beforehand.